Published in Respiratory Therapeutics Week, February 20th, 2006
The new study suggests that a mutation, known as mucA, in the bacterium Pseudomonas aeruginosa that grows within the deadly, lung-clogging mucous found in the airways of CF patients, also represents a fatal flaw that could help clear the characteristic "goop" from the lungs of patients with advanced disease. Researchers say the same genetic change that turns P. aeruginosa into a sticky, antibiotic-resistant...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Respiratory Therapeutics Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.